The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity

Background & Aims The current definition of the pattern of liver injury in hepatotoxicity (DILI) is given by the R (ratio) value, dividing alanine aminotransferase (ALT) and alkaline phosphatase (ALP) in upper limits of normal at DILI onset. We aimed to explore the validity of using aspartate am...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Liver international 2015-11, Vol.35 (11), p.2474-2482
Hauptverfasser: Robles-Diaz, Mercedes, Garcia-Cortes, Miren, Medina-Caliz, Inmaculada, Gonzalez-Jimenez, Andres, Gonzalez-Grande, Rocio, Navarro, Jose M., Castiella, Agustin, Zapata, Eva M., Romero-Gomez, Manuel, Blanco, Sonia, Soriano, German, Hidalgo, Ramon, Ortega-Torres, Maria, Clavijo, Encarnacion, Bermudez-Ruiz, Pilar M., Lucena, M. Isabel, Andrade, Raúl J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2482
container_issue 11
container_start_page 2474
container_title Liver international
container_volume 35
creator Robles-Diaz, Mercedes
Garcia-Cortes, Miren
Medina-Caliz, Inmaculada
Gonzalez-Jimenez, Andres
Gonzalez-Grande, Rocio
Navarro, Jose M.
Castiella, Agustin
Zapata, Eva M.
Romero-Gomez, Manuel
Blanco, Sonia
Soriano, German
Hidalgo, Ramon
Ortega-Torres, Maria
Clavijo, Encarnacion
Bermudez-Ruiz, Pilar M.
Lucena, M. Isabel
Andrade, Raúl J.
description Background & Aims The current definition of the pattern of liver injury in hepatotoxicity (DILI) is given by the R (ratio) value, dividing alanine aminotransferase (ALT) and alkaline phosphatase (ALP) in upper limits of normal at DILI onset. We aimed to explore the validity of using aspartate aminotransferase (AST) and gamma‐glutamyl transpeptidase (GGT) as biomarkers of hepatocelullar and cholestatic damage, respectively, when calculating the R value. Methods Clinical, laboratory and histological data from 588 DILI episodes included in the Spanish DILI Registry were analyzed. Linear regression analysis was performed to establish the most appropriate cut‐off points for hepatocellular and cholestatic patterns when calculating R with AST and GGT. Results The overall agreement between ALT/ALP and AST/ALP was 76%, with 96%, 61% and 41% agreement in the hepatocellular (R ≥ 5), cholestatic (R ≤ 2) and mixed groups respectively (P 
doi_str_mv 10.1111/liv.12834
format Article
fullrecord <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1111_liv_12834</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_WNG_K7N0BVJN_F</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4994-465142e88efbc9409caf0c63efabe64f3b922bdd2ec0bc11946ba4066cba77343</originalsourceid><addsrcrecordid>eNp1kMtOAyEUhonReF_4Aoati2lhoDPDUo33pm68LMmBOaPo3AJU7ds7ttqdbCDnfP8f8hFyxNmID2dcu48RTwshN8gul3mRiFTwzfU7FTtkL4Q3xrhSE75NdtJJwZTkape0D69IP6CeI-0qGtDPGwqhBx8hIoXGtV300IYKPYRh0Jb0BZoGkpd6HqFZ1HS57jG6cgkEalzXgH9HH6hr6Sv2ELvYfTnr4uKAbFVQBzz8vffJ4-XFw_l1Mr2_ujk_nSZWKiUTmU24TLEosDJWSaYsVMxmAiswmMlKGJWmpixTtMxYzpXMDEiWZdZAngsp9snJqtf6LgSPle69G3610JzpH2d6cKaXzgb2eMX2c9NguSb_JA3AeAV8uhoX_zfp6c3TX2WySrgQ8WudGKzoLBf5RD_PrvRdPmNnT7czfSm-AYlriKk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Robles-Diaz, Mercedes ; Garcia-Cortes, Miren ; Medina-Caliz, Inmaculada ; Gonzalez-Jimenez, Andres ; Gonzalez-Grande, Rocio ; Navarro, Jose M. ; Castiella, Agustin ; Zapata, Eva M. ; Romero-Gomez, Manuel ; Blanco, Sonia ; Soriano, German ; Hidalgo, Ramon ; Ortega-Torres, Maria ; Clavijo, Encarnacion ; Bermudez-Ruiz, Pilar M. ; Lucena, M. Isabel ; Andrade, Raúl J.</creator><creatorcontrib>Robles-Diaz, Mercedes ; Garcia-Cortes, Miren ; Medina-Caliz, Inmaculada ; Gonzalez-Jimenez, Andres ; Gonzalez-Grande, Rocio ; Navarro, Jose M. ; Castiella, Agustin ; Zapata, Eva M. ; Romero-Gomez, Manuel ; Blanco, Sonia ; Soriano, German ; Hidalgo, Ramon ; Ortega-Torres, Maria ; Clavijo, Encarnacion ; Bermudez-Ruiz, Pilar M. ; Lucena, M. Isabel ; Andrade, Raúl J. ; Spanish DILI Registry ; Faster Evidence-based Translation (SAFE-T) Consortium</creatorcontrib><description>Background &amp; Aims The current definition of the pattern of liver injury in hepatotoxicity (DILI) is given by the R (ratio) value, dividing alanine aminotransferase (ALT) and alkaline phosphatase (ALP) in upper limits of normal at DILI onset. We aimed to explore the validity of using aspartate aminotransferase (AST) and gamma‐glutamyl transpeptidase (GGT) as biomarkers of hepatocelullar and cholestatic damage, respectively, when calculating the R value. Methods Clinical, laboratory and histological data from 588 DILI episodes included in the Spanish DILI Registry were analyzed. Linear regression analysis was performed to establish the most appropriate cut‐off points for hepatocellular and cholestatic patterns when calculating R with AST and GGT. Results The overall agreement between ALT/ALP and AST/ALP was 76%, with 96%, 61% and 41% agreement in the hepatocellular (R ≥ 5), cholestatic (R ≤ 2) and mixed groups respectively (P &lt; 0.001). Classified by the causative drug, the agreement was higher (87–95%) among drug classes that mainly present with hepatocellular damage and lower (48–58%) for those in which cholestatic‐mixed injury predominate (P &lt; 0.001)). The overall agreement between ALT/ALP and ALT/GGT was weak (59%), except for in hepatocellular cases that showed a good agreement (94%) (P = 0.001). Pattern of injury according to liver histology demonstrated 65%, 68% and 47% agreement for ALT/ALP, AST/ALP and ALT/GGT ratios respectively. Conclusions AST can reliably replace ALT when calculating pattern of liver injury in DILI, while GGT can only substitute ALP when the R value scores as hepatocellular. The biochemical signature of causative drugs does influence the validity of the ratios with AST or GGT.</description><identifier>ISSN: 1478-3223</identifier><identifier>EISSN: 1478-3231</identifier><identifier>DOI: 10.1111/liv.12834</identifier><identifier>PMID: 25809419</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Alanine Transaminase - blood ; Alkaline Phosphatase - blood ; aspartate aminotransferase ; Aspartate Aminotransferases - blood ; Biomarkers - blood ; Chemical and Drug Induced Liver Injury - blood ; Chemical and Drug Induced Liver Injury - diagnosis ; Child ; drug-induced liver injury ; Female ; gamma-glutamyl transpeptidase ; gamma-Glutamyltransferase - blood ; hepatotoxicity ; Humans ; Linear Models ; Liver - pathology ; Male ; Middle Aged ; pattern of injury ; Prospective Studies ; R ratio value ; Young Adult</subject><ispartof>Liver international, 2015-11, Vol.35 (11), p.2474-2482</ispartof><rights>2015 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><rights>2015 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4994-465142e88efbc9409caf0c63efabe64f3b922bdd2ec0bc11946ba4066cba77343</citedby><cites>FETCH-LOGICAL-c4994-465142e88efbc9409caf0c63efabe64f3b922bdd2ec0bc11946ba4066cba77343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fliv.12834$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fliv.12834$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25809419$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Robles-Diaz, Mercedes</creatorcontrib><creatorcontrib>Garcia-Cortes, Miren</creatorcontrib><creatorcontrib>Medina-Caliz, Inmaculada</creatorcontrib><creatorcontrib>Gonzalez-Jimenez, Andres</creatorcontrib><creatorcontrib>Gonzalez-Grande, Rocio</creatorcontrib><creatorcontrib>Navarro, Jose M.</creatorcontrib><creatorcontrib>Castiella, Agustin</creatorcontrib><creatorcontrib>Zapata, Eva M.</creatorcontrib><creatorcontrib>Romero-Gomez, Manuel</creatorcontrib><creatorcontrib>Blanco, Sonia</creatorcontrib><creatorcontrib>Soriano, German</creatorcontrib><creatorcontrib>Hidalgo, Ramon</creatorcontrib><creatorcontrib>Ortega-Torres, Maria</creatorcontrib><creatorcontrib>Clavijo, Encarnacion</creatorcontrib><creatorcontrib>Bermudez-Ruiz, Pilar M.</creatorcontrib><creatorcontrib>Lucena, M. Isabel</creatorcontrib><creatorcontrib>Andrade, Raúl J.</creatorcontrib><creatorcontrib>Spanish DILI Registry</creatorcontrib><creatorcontrib>Faster Evidence-based Translation (SAFE-T) Consortium</creatorcontrib><title>The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity</title><title>Liver international</title><addtitle>Liver Int</addtitle><description>Background &amp; Aims The current definition of the pattern of liver injury in hepatotoxicity (DILI) is given by the R (ratio) value, dividing alanine aminotransferase (ALT) and alkaline phosphatase (ALP) in upper limits of normal at DILI onset. We aimed to explore the validity of using aspartate aminotransferase (AST) and gamma‐glutamyl transpeptidase (GGT) as biomarkers of hepatocelullar and cholestatic damage, respectively, when calculating the R value. Methods Clinical, laboratory and histological data from 588 DILI episodes included in the Spanish DILI Registry were analyzed. Linear regression analysis was performed to establish the most appropriate cut‐off points for hepatocellular and cholestatic patterns when calculating R with AST and GGT. Results The overall agreement between ALT/ALP and AST/ALP was 76%, with 96%, 61% and 41% agreement in the hepatocellular (R ≥ 5), cholestatic (R ≤ 2) and mixed groups respectively (P &lt; 0.001). Classified by the causative drug, the agreement was higher (87–95%) among drug classes that mainly present with hepatocellular damage and lower (48–58%) for those in which cholestatic‐mixed injury predominate (P &lt; 0.001)). The overall agreement between ALT/ALP and ALT/GGT was weak (59%), except for in hepatocellular cases that showed a good agreement (94%) (P = 0.001). Pattern of injury according to liver histology demonstrated 65%, 68% and 47% agreement for ALT/ALP, AST/ALP and ALT/GGT ratios respectively. Conclusions AST can reliably replace ALT when calculating pattern of liver injury in DILI, while GGT can only substitute ALP when the R value scores as hepatocellular. The biochemical signature of causative drugs does influence the validity of the ratios with AST or GGT.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alanine Transaminase - blood</subject><subject>Alkaline Phosphatase - blood</subject><subject>aspartate aminotransferase</subject><subject>Aspartate Aminotransferases - blood</subject><subject>Biomarkers - blood</subject><subject>Chemical and Drug Induced Liver Injury - blood</subject><subject>Chemical and Drug Induced Liver Injury - diagnosis</subject><subject>Child</subject><subject>drug-induced liver injury</subject><subject>Female</subject><subject>gamma-glutamyl transpeptidase</subject><subject>gamma-Glutamyltransferase - blood</subject><subject>hepatotoxicity</subject><subject>Humans</subject><subject>Linear Models</subject><subject>Liver - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>pattern of injury</subject><subject>Prospective Studies</subject><subject>R ratio value</subject><subject>Young Adult</subject><issn>1478-3223</issn><issn>1478-3231</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOAyEUhonReF_4Aoati2lhoDPDUo33pm68LMmBOaPo3AJU7ds7ttqdbCDnfP8f8hFyxNmID2dcu48RTwshN8gul3mRiFTwzfU7FTtkL4Q3xrhSE75NdtJJwZTkape0D69IP6CeI-0qGtDPGwqhBx8hIoXGtV300IYKPYRh0Jb0BZoGkpd6HqFZ1HS57jG6cgkEalzXgH9HH6hr6Sv2ELvYfTnr4uKAbFVQBzz8vffJ4-XFw_l1Mr2_ujk_nSZWKiUTmU24TLEosDJWSaYsVMxmAiswmMlKGJWmpixTtMxYzpXMDEiWZdZAngsp9snJqtf6LgSPle69G3610JzpH2d6cKaXzgb2eMX2c9NguSb_JA3AeAV8uhoX_zfp6c3TX2WySrgQ8WudGKzoLBf5RD_PrvRdPmNnT7czfSm-AYlriKk</recordid><startdate>201511</startdate><enddate>201511</enddate><creator>Robles-Diaz, Mercedes</creator><creator>Garcia-Cortes, Miren</creator><creator>Medina-Caliz, Inmaculada</creator><creator>Gonzalez-Jimenez, Andres</creator><creator>Gonzalez-Grande, Rocio</creator><creator>Navarro, Jose M.</creator><creator>Castiella, Agustin</creator><creator>Zapata, Eva M.</creator><creator>Romero-Gomez, Manuel</creator><creator>Blanco, Sonia</creator><creator>Soriano, German</creator><creator>Hidalgo, Ramon</creator><creator>Ortega-Torres, Maria</creator><creator>Clavijo, Encarnacion</creator><creator>Bermudez-Ruiz, Pilar M.</creator><creator>Lucena, M. Isabel</creator><creator>Andrade, Raúl J.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201511</creationdate><title>The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity</title><author>Robles-Diaz, Mercedes ; Garcia-Cortes, Miren ; Medina-Caliz, Inmaculada ; Gonzalez-Jimenez, Andres ; Gonzalez-Grande, Rocio ; Navarro, Jose M. ; Castiella, Agustin ; Zapata, Eva M. ; Romero-Gomez, Manuel ; Blanco, Sonia ; Soriano, German ; Hidalgo, Ramon ; Ortega-Torres, Maria ; Clavijo, Encarnacion ; Bermudez-Ruiz, Pilar M. ; Lucena, M. Isabel ; Andrade, Raúl J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4994-465142e88efbc9409caf0c63efabe64f3b922bdd2ec0bc11946ba4066cba77343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alanine Transaminase - blood</topic><topic>Alkaline Phosphatase - blood</topic><topic>aspartate aminotransferase</topic><topic>Aspartate Aminotransferases - blood</topic><topic>Biomarkers - blood</topic><topic>Chemical and Drug Induced Liver Injury - blood</topic><topic>Chemical and Drug Induced Liver Injury - diagnosis</topic><topic>Child</topic><topic>drug-induced liver injury</topic><topic>Female</topic><topic>gamma-glutamyl transpeptidase</topic><topic>gamma-Glutamyltransferase - blood</topic><topic>hepatotoxicity</topic><topic>Humans</topic><topic>Linear Models</topic><topic>Liver - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>pattern of injury</topic><topic>Prospective Studies</topic><topic>R ratio value</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robles-Diaz, Mercedes</creatorcontrib><creatorcontrib>Garcia-Cortes, Miren</creatorcontrib><creatorcontrib>Medina-Caliz, Inmaculada</creatorcontrib><creatorcontrib>Gonzalez-Jimenez, Andres</creatorcontrib><creatorcontrib>Gonzalez-Grande, Rocio</creatorcontrib><creatorcontrib>Navarro, Jose M.</creatorcontrib><creatorcontrib>Castiella, Agustin</creatorcontrib><creatorcontrib>Zapata, Eva M.</creatorcontrib><creatorcontrib>Romero-Gomez, Manuel</creatorcontrib><creatorcontrib>Blanco, Sonia</creatorcontrib><creatorcontrib>Soriano, German</creatorcontrib><creatorcontrib>Hidalgo, Ramon</creatorcontrib><creatorcontrib>Ortega-Torres, Maria</creatorcontrib><creatorcontrib>Clavijo, Encarnacion</creatorcontrib><creatorcontrib>Bermudez-Ruiz, Pilar M.</creatorcontrib><creatorcontrib>Lucena, M. Isabel</creatorcontrib><creatorcontrib>Andrade, Raúl J.</creatorcontrib><creatorcontrib>Spanish DILI Registry</creatorcontrib><creatorcontrib>Faster Evidence-based Translation (SAFE-T) Consortium</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Liver international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robles-Diaz, Mercedes</au><au>Garcia-Cortes, Miren</au><au>Medina-Caliz, Inmaculada</au><au>Gonzalez-Jimenez, Andres</au><au>Gonzalez-Grande, Rocio</au><au>Navarro, Jose M.</au><au>Castiella, Agustin</au><au>Zapata, Eva M.</au><au>Romero-Gomez, Manuel</au><au>Blanco, Sonia</au><au>Soriano, German</au><au>Hidalgo, Ramon</au><au>Ortega-Torres, Maria</au><au>Clavijo, Encarnacion</au><au>Bermudez-Ruiz, Pilar M.</au><au>Lucena, M. Isabel</au><au>Andrade, Raúl J.</au><aucorp>Spanish DILI Registry</aucorp><aucorp>Faster Evidence-based Translation (SAFE-T) Consortium</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity</atitle><jtitle>Liver international</jtitle><addtitle>Liver Int</addtitle><date>2015-11</date><risdate>2015</risdate><volume>35</volume><issue>11</issue><spage>2474</spage><epage>2482</epage><pages>2474-2482</pages><issn>1478-3223</issn><eissn>1478-3231</eissn><abstract>Background &amp; Aims The current definition of the pattern of liver injury in hepatotoxicity (DILI) is given by the R (ratio) value, dividing alanine aminotransferase (ALT) and alkaline phosphatase (ALP) in upper limits of normal at DILI onset. We aimed to explore the validity of using aspartate aminotransferase (AST) and gamma‐glutamyl transpeptidase (GGT) as biomarkers of hepatocelullar and cholestatic damage, respectively, when calculating the R value. Methods Clinical, laboratory and histological data from 588 DILI episodes included in the Spanish DILI Registry were analyzed. Linear regression analysis was performed to establish the most appropriate cut‐off points for hepatocellular and cholestatic patterns when calculating R with AST and GGT. Results The overall agreement between ALT/ALP and AST/ALP was 76%, with 96%, 61% and 41% agreement in the hepatocellular (R ≥ 5), cholestatic (R ≤ 2) and mixed groups respectively (P &lt; 0.001). Classified by the causative drug, the agreement was higher (87–95%) among drug classes that mainly present with hepatocellular damage and lower (48–58%) for those in which cholestatic‐mixed injury predominate (P &lt; 0.001)). The overall agreement between ALT/ALP and ALT/GGT was weak (59%), except for in hepatocellular cases that showed a good agreement (94%) (P = 0.001). Pattern of injury according to liver histology demonstrated 65%, 68% and 47% agreement for ALT/ALP, AST/ALP and ALT/GGT ratios respectively. Conclusions AST can reliably replace ALT when calculating pattern of liver injury in DILI, while GGT can only substitute ALP when the R value scores as hepatocellular. The biochemical signature of causative drugs does influence the validity of the ratios with AST or GGT.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>25809419</pmid><doi>10.1111/liv.12834</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1478-3223
ispartof Liver international, 2015-11, Vol.35 (11), p.2474-2482
issn 1478-3223
1478-3231
language eng
recordid cdi_crossref_primary_10_1111_liv_12834
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adolescent
Adult
Aged
Aged, 80 and over
Alanine Transaminase - blood
Alkaline Phosphatase - blood
aspartate aminotransferase
Aspartate Aminotransferases - blood
Biomarkers - blood
Chemical and Drug Induced Liver Injury - blood
Chemical and Drug Induced Liver Injury - diagnosis
Child
drug-induced liver injury
Female
gamma-glutamyl transpeptidase
gamma-Glutamyltransferase - blood
hepatotoxicity
Humans
Linear Models
Liver - pathology
Male
Middle Aged
pattern of injury
Prospective Studies
R ratio value
Young Adult
title The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T20%3A31%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20value%20of%20serum%20aspartate%20aminotransferase%20and%20gamma-glutamyl%20transpetidase%20as%20biomarkers%20in%20hepatotoxicity&rft.jtitle=Liver%20international&rft.au=Robles-Diaz,%20Mercedes&rft.aucorp=Spanish%20DILI%20Registry&rft.date=2015-11&rft.volume=35&rft.issue=11&rft.spage=2474&rft.epage=2482&rft.pages=2474-2482&rft.issn=1478-3223&rft.eissn=1478-3231&rft_id=info:doi/10.1111/liv.12834&rft_dat=%3Cistex_cross%3Eark_67375_WNG_K7N0BVJN_F%3C/istex_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/25809419&rfr_iscdi=true